A study of inter-alpha-trypsin inhibitor chains expression in liposarcomas

European Journal of Surgical Oncology

Volumn 29, Issue 8, 2003, Pages 665-669

  Tabata, I ^a   Nishida, Yoshihiro ^a   Sugiura, H ^a   Zhuo, L ^b   Yoneda, M ^c   Kimata, K ^b   Nakashima, H ^a   Ishiguro, N ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

^c Aichi Prefect Col of Nursing/Hlth   (Japan)

Author keywords

Heavy chain; Inter trypsin inhibitor; Liposarcoma; Prognosis

Indexed keywords

HYALURONIC ACID; INTER ALPHA TRYPSIN INHIBITOR; MESSENGER RNA;

ARTICLE; BLOOD LEVEL; CANCER CLASSIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPOMA; LIPOSARCOMA; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SOFT TISSUE SARCOMA; TUMOR GROWTH; UPREGULATION;

EID: 0141920400     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(03)00135-5     Document Type: Article

References (24)

1. Salier JP, Diarra-Mehrpour M, Sesboue R, Bourguignon J, Benarous R, Ohkubo I et al. Isolation and characterization of cDNAs encoding the heavy chain of human inter-alpha-trypsin inhibitor (I alpha TI): unambiguous evidence for multipolypeptide chain structure of I alpha TI. Proc Natl Acad Sci USA 1987; 84: 8272-6.
2. Gebhard W, Schreitmuller T, Hochstrasser K, Wachter E. Complementary DNA and derived amino acid sequence of the precursor of one of the three protein components of the inter-alpha-trypsin inhibitor complex. FEBS Lett 1988; 229: 63-7.
3. Gebhard W, Schreitmuller T, Hochstrasser K, Wachter E. Two out of the three kinds of subunits of inter-alpha-trypsin inhibitor are structurally related. Eur J Biochem 1989; 181: 571-6.
4. Diarra-Mehrpour M, Bourguignon J, Bost F, Sesboue R, Muschio F, Sarafan N et al. Human inter-alpha-trypsin inhibitor: full-length cDNA sequence of the heavy chain HI. Biochim Biophys Acta 1992; 1132: 114-8.
5. Chen L, Mao SJ, McLean LR, Powers RW, Larsen WJ. Proteins of the inter-alpha-trypsin inhibitor family stabilize the cumulus extracellular matrix through their direct binding with hyaluronic acid. J Biol Chem 1994; 269: 28282-7.
6. Chen L, Mao SJ, Larsen WJ. Identification of a factor in fetal bovine serum that stabilizes the cumulus extracellular matrix. A role for a member of the inter-alpha-trypsin inhibitor family. J Biol Chem 1992; 267: 12380-6.
7. Camaioni A, Hascall VC, Yanagishita M, Salustri A. Effects of exogenous hyaluronic acid and serum on matrix organization and stability in the mouse cumulus cell-oocyte complex. J Biol Chem 1993; 268: 20473-81.
8. Kimata K, Honma Y, Okayama M, Oguri K, Hozomi M, Suzuki S. Increased synthesis of hyaluronic acid by mouse mammary carcinoma cell variants with high metastatic potential. Cancer Res 1983; 43: 1347-54.
9. Antilla MA, Tammi RH, Tammi MI, Syrjanen KJ, Saarikoski SV, Kosma VM. High levels of stromal hyaluronan redict poor disease outcome in epithelial ovarian cancer. Cancer Res 2000; 60: 150-5.
10. Knight JC, Renwick PJ, Cin PD, van den Berghe H, Fletcher CD. Translocation t(12;16)(q13;p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis. Cancer Res 1995; 55: 24-7.
11. Yoneda M, Suzuki S, Kimata K. Hyaluronan acid associated with the surfaces of culutured fibroblasts is linked to a serum-derived 85-kDa protein. J Biol Chem 1990; 265: 5247-57.
12. Huang L, Yoneda M, Kimata K. A serum-derived hyaluronan-associated protein (SHAP) is the heavy chain of the inter α-trypsin inhibitor. J Biol Chem 1993; 268: 26725-30.
13. Zhao M, Yoneda M, Ohashi Y, Kurono S, Iwata H, Onuki Y et al. Evidence for the covalent binding of SHAP, heavy chains of inter-α-trypsin inhibitor, to hyaluronan. J Biol Chem 1995; 270: 26657-63.
14. Enghild JJ, Salvesen G, Thogersen IB, Pizzo SV, Hefta SA. Presence of the protein-glycosaminoglycan-protein covalent cross-link in the inter-a-inhibitor related proteinase inhibitor heavy chain 2/bikunin. J Biol Chem 1993; 268: 8711-6.
15. Enghild JJ, Salvesen G, Hefta SA, Thogersen IB, Rutherfurd S, Pizzo SV. Chondroitin 4-sulfate covalently cross-links the chains of the human blood protein pre-a-inhibitor. J Biol Chem 1991; 266: 747-51.
16. Itoh H, Tomita M, Kobayashi T, Uchino H, Maruyama H, Nawa Y. Expression of inter-a-trypsin inhibitor light chain (bikunin) in human pancreas. J Biochem 1996; 120: 271-5.
17. Odum L, Nielsen HW. Human protein HC (a-I-microglobulin) and inter-a-trypsin inhibitor in connective tissue. Histochem J 1994; 26: 799-803.
18. Yoshida E, Maruyama M, Sugiki M, Mihara H. Immunohistochemical demonstration of bikunin, a light chain of inter-a-trypsin inhibitor, in human brain tumors. Inflammation 1994; 18: 589-96.
19. Kida D, Yoneda M, Miyaura S, Ishimaru T, Yoshida Y, Ito T et al. The SHAP-HA complex in sera from patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 1999; 26: 1230-8.
20. Evans HL. Liposarcoma: a study of 55 cases with a reassessment of its classification. Am J Surg Pathol 1979; 3: 507-23.
21. Bolen JW, Thorning D. Liposarcoma: a histogenetic approach to the classification of adipose tissue neoplasms. Am J Surg Pathol 1984; 8: 3-17.
22. Pilotti S, Della Torre G, Lavarino C, Di Palma S, Sozzi G, Minoletti F et al. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms. J Pathol 1997; 181: 14-24.
23. Rubin BP, Fletcher CDM. The cytogenetics of lipomatous tumors. Histopathology 1997; 30: 507-11.
24. Tallini G, Cin P, Rhoden KJ, Chiapetta G, Manfioletti G, Giancotti V et al. Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors: immunohistochemical reactivity correlates with karyotypic alterations. Am J Pathol 1997; 151: 37-43.